Autolus Therapeutics Unearned Premium on Insurance Contract (Quarterly) Analysis

Autolus Therapeutics Plc (AUTL)

1.725 +0.06 (+3.29%) USD | NASDAQ | Feb 23, 10:10

View Unearned Premium on Insurance Contract (Quarterly) for AUTL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Unearned Premium on Insurance Contract (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Unearned Premium on Insurance Contract (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Unearned Premium on Insurance Contract (Quarterly) Benchmarks

Start Trial

Biodexa Pharmaceuticals Plc	--
NuCana Plc	--
Mereo BioPharma Group Plc	--
Bicycle Therapeutics Plc	--
DBV Technologies SA	--